close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ADMA Biologics, Inc.

< Previous 1 2 Next >
News headline image
ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces CFO Transition
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Amendment to Credit Agreement
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Proposed Public Offering of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
News headline image
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today